Jade Biosciences Inc. (JBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jade Biosciences Inc.

    NASDAQ: JBIO · Real-Time Price · USD
    7.77
    -0.01 (-0.13%)
    At close: Sep 05, 2025, 3:59 PM
    7.92
    1.93%
    After-hours: Sep 05, 2025, 06:58 PM EDT

    Jade Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 282K 96K 68K 15K
    Gross Profit
    		 -282K -96K -68K -15K
    Operating Income
    		 -71.08K -81.41M -53.24M -23.02M
    Interest Income
    		 5.04M 5.95M 1.83M 65K
    Pretax Income
    		 -93.96K -75.47M -51.49M -22.96M
    Net Income
    		 -93.96K -75.52M -51.51M -22.96M
    Selling & General & Admin
    		 8.61K 17.09M 14.55M 8.02M
    Research & Development
    		 62.47K 64.22M 38.62M 14.99M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 71.08K 81.31M 53.17M 23.01M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 71.08K 81.41M 53.24M 23.02M
    Income Tax Expense
    		 n/a 56K 25K 3K
    Shares Outstanding (Basic)
    		 5K 752.33K 699.2K 697.44K
    Shares Outstanding (Diluted)
    		 5K 752.33K 699.2K 697.44K
    EPS (Basic)
    		 -18.79 -100.38 -73.67 -32.96
    EPS (Diluted)
    		 -18.79 -100.38 -73.67 -32.96
    EBITDA
    		 n/a -75.37M -51.42M -22.95M
    EBIT
    		 -64.48K -75.47M -51.49M -22.96M
    Depreciation & Amortization
    		 64.48K 96K 68K 15K

    Add to Watchlist